Effect of supplementation with high-selenium yeast on plasma lipids: A randomized trial

Annals of Internal Medicine

Volumn 154, Issue 10, 2011, Pages 656-665

  Rayman, Margaret P ^a   Stranges, Saverio ^b   Griffin, Bruce A ^a   Pastor Barriuso, Roberto ^c   Guallar, Eliseo ^d  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; PLACEBO; SELENIUM;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UNITED KINGDOM; YEAST;

EID: 79956355684     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-154-10-201105170-00005     Document Type: Article

References (50)

1. Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet. 1982;2:175-179. [PMID: 6123886]
2. Nève J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk. 1996;3:42-47. [PMID: 8783029]
3. Brigelius-Flohé R, Banning A, Schnurr K. Selenium-dependent enzymes in endothelial cell function. Antioxid Redox Signal. 2003;5:205-215. [PMID: 12716480]
4. Sattler W, Maiorino M, Stocker R. Reduction of HDL- and LDL-associated cholesterylester and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and Ebselen (PZ 51). Arch Biochem Biophys. 1994;309: 214-221. [PMID: 8135530]
5. Salonen JT, Salonen R, Seppänen K, Kantola M, Parviainen M, Alfthan G, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis. 1988;70:155-160. [PMID: 3258519]
6. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, et al; AtheroGene Investigators. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med. 2003;349: 1605-1613. [PMID: 14573732]
7. Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, Thompson JT, et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem. 2007;282:17964-17973.[PMID: 17439952]
8. Gao Y, Hannan NR, Wanyonyi S, Konstantopolous N, Pagnon J, Feng HC, et al. Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine. 2006;33:246-251. [PMID: 16574427]
9. Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, et al. Genetic variation in selenoprotein S influences inflammatory response. Nat Genet. 2005;37:1234-1241. [PMID: 16227999]
10. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84:762-773.[PMID: 17023702]
11. Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol. 2006;163:694-699. [PMID: 16495471]
12. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842-857. [PMID: 17327526]
13. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39-51. [PMID: 19066370]
14. Stranges S, Navas-Acien A, Rayman MP, Guallar E. Selenium status and cardiometabolic health: state of the evidence. Nutr Metab Cardiovasc Dis. 2010; 20:754-760. [PMID: 21094028]
15. Jossa F, Trevisan M, Krogh V, Farinaro E, Giumetti D, Fusco G, et al. Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis. 1991;87:129-134. [PMID: 1854360]
16. Suadicani P, Hein HO, Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis. 1992;96:33-42. [PMID: 1418100]
17. Gámez C, Ruiz-López D, Artacho R, Navarro M, Puerta A, López C. Serum selenium in institutionalized elderly subjects and relation to other nutritional markers [Letter]. Clin Chem. 1997;43:693-694. [PMID: 9105278]
18. Coudray C, Roussel AM, Mainard F, Arnaud J, Favier A. Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J Am Coll Nutr. 1997;16:584-591. [PMID: 9430087]
19. Bleys J, Navas-Acien A, Stranges S, Menke A, Miller ER 3rd, Guallar E. Serum selenium and serum lipids in US adults. Am J Clin Nutr. 2008;88:416-423. [PMID: 18689378]
20. Laclaustra M, Stranges S, Navas-Acien A, Ordovas JM, Guallar E. Serum selenium and serum lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Atherosclerosis. 2010;210: 643-648. [PMID: 20102763]
21. Stranges S, Laclaustra M, Ji C, Cappuccio FP, Navas-Acien A, Ordovas JM, et al. Higher selenium status is associated with adverse blood lipid profile in British adults. J Nutr. 2010;140:81-87. [PMID: 19906812]
22. Yang KC, Lee LT, Lee YS, Huang HY, Chen CY, Huang KC. Serum selenium concentration is associated with metabolic factors in the elderly: a crosssectional study. Nutr Metab (Lond). 2010;7:38. [PMID: 20459618]
23. Bates CJ, Thane CW, Prentice A, Delves HT. Selenium status and its correlates in a British national diet and nutrition survey: people aged 65 years and over. J Trace Elem Med Biol. 2002;16:1-8. [PMID: 11878747]
24. Salonen JT, Salonen R, Seppänen K, Kantola M, Parviainen M, Alfthan G, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis. 1988;70:155-160. [PMID: 3258519]
25. Luoma PV, Sotaniemi EA, Korpela H, Kumpulainen J. Serum selenium, glutathione peroxidase activity and high-density lipoprotein cholesterol-effect of selenium supplementation. Res Commun Chem Pathol Pharmacol. 1984;46: 469-472. [PMID: 6515133]
26. Yu SY, Mao BL, Xiao P, Yu WP, Wang YL, Huang CZ, et al. Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China. A pilot study. Biol Trace Elem Res. 1990;24:105-108. [PMID: 1702663]
27. Rayman M, Thompson A, Warren-Perry M, Galassini R, Catterick J, Hall E, et al. Impact of selenium on mood and quality of life: a randomized, controlled trial. Biol Psychiatry. 2006;59:147-154. [PMID: 16181615]
28. Rayman MP, Thompson AJ, Bekaert B, Catterick J, Galassini R, Hall E, et al. Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am J Clin Nutr. 2008; 87:370-378. [PMID: 18258627]
29. Bekaert B, Cooper ML, Green FR, McNulty H, Pentieva K, Scott JM, et al. Effect of selenium status and supplementation with high-selenium yeast on plasma homocysteine and B vitamin concentrations in the UK elderly. Mol Nutr Food Res. 2008;52:1324-1333. [PMID: 18683819]
30. Lide DR, ed. CRC Handbook of Chemistry and Physics. 74th ed. Boca Raton, FL: CRC Pr; 1993-1994.
31. Wolf NM, Mueller K, Hirche F, Most E, Pallauf J, Mueller AS. Study of molecular targets influencing homocysteine and cholesterol metabolism in growing rats by manipulation of dietary selenium and methionine concentrations. Br J Nutr. 2010;104:520-532. [PMID: 20350341]
32. Dhingra S, Bansal MP. Hypercholesterolemia and apolipoprotein B expression: regulation by selenium status. Lipids Health Dis. 2005;4:28. [PMID: 16271152]
33. Mazur A, Nassir F, Gueux E, Moundras C, Bellanger J, Grolier P, et al. Diets deficient in selenium and vitamin E affect plasma lipoprotein and apolipoprotein concentrations in the rat. Br J Nutr. 1996;76:899-907. [PMID: 9014658]
34. Wójcicki J, Rózewicka L, Barcew-Wiszniewska B, Samochowiec L, Juźwiak S, Kadłubowska D, et al. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis. 1991;87:9-16. [PMID: 1670289]
35. Sengupta A, Carlson BA, Hoffmann VJ, Gladyshev VN, Hatfield DL. Loss of housekeeping selenoprotein expression in mouse liver modulates lipoprotein metabolism. Biochem Biophys Res Commun. 2008;365:446-452. [PMID: 17996733]
36. Moosmann B, Behl C. Selenoprotein synthesis and side-effects of statins. Lancet. 2004;363:892-894. [PMID: 15031036]
37. Arnaud J, Akbaraly TN, Hininger-Favier I, Berr C, Roussel AM. Fibrates but not statins increase plasma selenium in dyslipidemic aged patients-the EVA study. J Trace Elem Med Biol. 2009;23:21-28. [PMID: 19203713]
38. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391:79-82. [PMID: 9422508]
39. Touyz RM, Schiffrin EL. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Vascul Pharmacol. 2006;45:19-28. [PMID: 16782410]
40. Klopotek A, Hirche F, Eder K. PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2. Exp Biol Med (Maywood). 2006;231:1365-1372. [PMID: 16946405]
41. Xun P, Liu K, Morris JS, Daviglus ML, He K. Longitudinal association between toenail selenium levels and measures of subclinical atherosclerosis: the CARDIA trace element study. Atherosclerosis. 2010;210:662-667. [PMID: 20138620]
42. Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr. 1999;70:896-903. [PMID: 10539752]
43. Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. 2008; 168:404-410. [PMID: 18299496]
44. Halloran P, Roetering H, Pisani T, van den Berg B, Cobbaert C. Reference standardization and analytical performance of a liquid homogeneous high-density lipoprotein cholesterol method compared with chemical precipitation method. Arch Pathol Lab Med. 1999;123:317-326. [PMID: 10320144]
45. Centers for Disease Control and Prevention (CDC); National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2003-2004. Accessed at www.cdc.gov/nchs/nhanes/nhanes2003-2004/nhanes03_04.htm on 23 March 2011.
46. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147:217-223. [PMID: 17620655]
47. Raudenbush SW, Bryk AS. Hierarchical Linear Models: Applications and Data Analysis Methods. 2nd ed. Thousand Oaks, CA: Sage; 2002.
48. Albert PS. Longitudinal data analysis (repeated measures) in clinical trials. Stat Med. 1999;18:1707-1732. [PMID: 10407239]
49. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6:356-365. [PMID: 7548341]
50. Diggle PJ, Heagerty P, Liang KY, Zeger SL. Analysis of Longitudinal Data. 2nd ed. Oxford, United Kingdom: Oxford Univ Pr; 2002.